Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Report: Russia hits pause on Sputnik-V COVID-19 vaccine trial

By Brian Buntz | November 3, 2020

COVID-19 vaccine

Image from Sam Moqadam on Unsplash

Russia is temporarily tapping the brakes on its Phase 3 COVID-19 vaccine trial as demand for its Sputnik-V vaccine surges, according to several clinical officials quoted by Reuters. 

Crocus Medical, a company helping administer the vaccine, denies there is a shortage of the vaccine. “Trials are ongoing, and there is sufficient vaccine supply,” said Alexey Butylin, managing director of Crocus Medical, in a statement to the news service.

According to The Lancet, experts outside of Russia have voiced skepticism regarding the vaccine, but it has some potential advantages. It is freeze-dried, circumventing the need for ultra-cold storage during transit. And its tolerability is comparable to the other adenovirus-vector vaccines, according to Dr. Peter Hotez, a vaccinologist at Baylor College of Medicine.

The Sputnik-V vaccine became the first COVID-19 vaccine to win regulatory approval when Russia’s Ministry of Health issued a registration certificate for the vaccine in August following a combined Phase 1 and Phase 2 trial for Sputnik V.

The vaccine requires two doses for full efficacy. According to Russian officials, 20,000 people have received the first dose and 9,000 the second.

The Lancet also published results from the combined Phase 1 and Phase 2 trial in September.

 


Filed Under: clinical trials, Drug Discovery, Infectious Disease
Tagged With: clinical trials, covid-19, COVID-19 vaccine, Crocus Medical, Sputnik-V, vaccine
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Comments

  1. N.T.S.De Costa says

    November 7, 2020 at 3:53 am

    Thanks to president Putin and all crew members of involving discover of sputnik v. This is a honest duty of Russians and a gift for world wide human beings. Thank you.

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE